I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Safety, tolerability, pharmacodynamic and wellbeing effects..:
Ellen James
;
David Erritzoe
;
Tiffanie Benway
...
https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1305796/full. , 2024
Link:
https://doi.org/10.3389/fpsyt.2023.1305796
RT Journal T1 <Title>Safety, tolerability, pharmacodynamic and wellbeing effects of SPL026 (dimethyltryptamine fumarate) in healthy participants: a randomized, placebo-controlled phase 1 trial</Title> UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:cbee5c85655e4709bea07b04421d3db3&Exemplar=1&LAN=DE A1 Ellen James A1 David Erritzoe A1 Tiffanie Benway A1 Zelah Joel A1 Christopher Timmermann A1 Meghan Good A1 Claudio Agnorelli A1 Brandon M. Weiss A1 Tommaso Barba A1 Graham Campbell A1 Michelle Baker Jones A1 Charlotte Hughes A1 Helen Topping A1 Malcolm Boyce A1 Carol Routledge PB Frontiers Media S.A. YR 2024 K1 dimethyltryptamine K1 major depressive disorder K1 pharmacodynamic K1 psychedelic K1 safety K1 tolerability K1 Psychiatry K1 RC435-571 JF https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1305796/full LK http://dx.doi.org/https://doi.org/10.3389/fpsyt.2023.1305796 DO https://doi.org/10.3389/fpsyt.2023.1305796 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
